In ESCC, procollagen-lysine two-oxoglutarate 5-dioxygenase 3 (PLOD3) is highly expressed and associated with favorable prognosis (Lin et al., 2024). This evidence concerns the gene PLOD3 and esophageal squamous cell carcinoma.